QIAGEN OmicSoft and Biomedical Knowledge Base
Using OmicSoft OncoLand to integrate public expression
58 views
QIAGEN OmicSoft Lands are high-quality curated repositories of genomics and proteomics data sourced from public, published studies (GEO, EBI, SRA) and consortia (TCGA, CPTAC, GTEx, and more). Because of our expert curation and stringent quality checks, OmicSoft users can deeply investigate across diverse oncology and normal tissue/cell datasets to discover and validate candidate drug targets and biomarkers.
In this training, attendees will use OmicSoft Studio, our graphical user interface, to access public data from The Cancer Genome Atlas (TCGA). Using this data, you will learn how to:
• View gene expression and somatic mutation frequency across different tumor types and conditions
• Identify genes whose expression correlates or anti-correlates with mutation of your target
• Prioritize your candidate biomarkers using expression data across comparisons (tumor vs. normal, MUT vs. WT, etc.)
• Establish survival consequences from changes in your candidate biomarker’s expression or mutation status
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...
High-quality biomedical relationships knowledge is the cornerstone of modern...
QIAGEN OmicSoft and Biomedical Knowledge Base
Supercharge your AI in drug discovery with high-quality biomedical data
If you’re working in pharma or biotech, you likely rely on artificial...
QIAGEN OmicSoft and Biomedical Knowledge Base
Unlocking the power of API-based 'omics queries
If you're a data scientist or bioinformatician working in biopharma, here's...
QIAGEN OmicSoft and Biomedical Knowledge Base
Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation
If you’re a data scientist or bioinformatician working in biopharma and need...